[Role of amphetamines in cancerology : a review of the literature].
The review of the literature shows that amphetamines (methylphenidate, dextroamphetamine) have been rarely used in the past, but have been recently introduced in the palliative treatment in oncology. They have stimulating, antidepressive and perhaps coanalgesic effects. They can alleviate sleepiness related to opiates analgesics which are given in chronic pain. Amphetamines may also be a therapeutic option, alone or in association with antidepressant drugs, in the pharmacological management of mood disorders unresponsive to tricyclics or selective serotonin reuptake inhibitors. These treatments are well-tolerated and are rapidly active. This treatment may improve the quality of life and comfort in cancer patients.
Reich
M G
MG
Service de médecine, centre Oscar-Lambret, Lille, France.
Razavi
D
D
D000928:Antidepressive Agents / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000494:pharmacology / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000209:etiology / Q000523:psychology; D004334:Drug Administration Schedule; D004361:Drug Tolerance; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000523:psychology; D010146:Pain / Q000188:drug therapy* / Q000523:psychology; D011788:Quality of Life
D000928:Antidepressive Agents; D000697:Central Nervous System Stimulants